Literature DB >> 24786746

Calculating length of gestation from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) database versus vital records may alter reported rates of prematurity.

Judy E Stern1, Milton Kotelchuck2, Barbara Luke3, Eugene Declercq4, Howard Cabral5, Hafsatou Diop6.   

Abstract

OBJECTIVE: To compare length of gestation after assisted reproductive technology (ART) as calculated by three methods from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) and vital records (birth and fetal death) in the Massachusetts Pregnancy to Early Life Longitudinal Data System (PELL).
DESIGN: Historical cohort study.
SETTING: Database linkage analysis. PATIENT(S): Live or stillborn deliveries. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): ART deliveries were linked to live birth or fetal death certificates. Length of gestation in 7,171 deliveries from fresh autologous ART cycles (2004-2008) was calculated and compared with that of SART CORS with the use of methods: M1 = outcome date - cycle start date; M2 = outcome date - transfer date + 17 days; and M3 = outcome date - transfer date + 14 days + day of transfer. Generalized estimating equation models were used to compare methods. RESULT(S): Singleton and multiple deliveries were included. Overall prematurity (delivery <37 weeks) varied by method of calculation: M1 29.1%; M2 25.6%; M3 25.2%; and PELL 27.2%. The SART methods, M1-M3, varied from those of PELL by ≥ 3 days in >45% of deliveries and by more than 1 week in >22% of deliveries. Each method differed from each other. CONCLUSION(S): Estimates of preterm birth in ART vary depending on source of data and method of calculation. Some estimates may overestimate preterm birth rates for ART conceptions.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ART; Gestational age; PELL; SART CORS; prematurity

Mesh:

Year:  2014        PMID: 24786746      PMCID: PMC4068145          DOI: 10.1016/j.fertnstert.2014.01.053

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  21 in total

1.  Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Christos Coutifaris; Thomas Molinaro; Kurt T Barnhart
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

2.  The effect of early fetal losses on singleton assisted-conception pregnancy outcomes.

Authors:  Barbara Luke; Morton B Brown; David A Grainger; Judy E Stern; Nancy Klein; Marcelle I Cedars
Journal:  Fertil Steril       Date:  2008-06-18       Impact factor: 7.329

3.  Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study.

Authors:  Sheree L Boulet; Laura A Schieve; Angela Nannini; Cynthia Ferre; Owen Devine; Bruce Cohen; Zi Zhang; Victoria Wright; Maurizio Macaluso
Journal:  Hum Reprod       Date:  2008-05-16       Impact factor: 6.918

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Births: final data for 2009.

Authors:  Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Michelle J K Osterman; Sharon Kirmeyer; T J Mathews; Elizabeth C Wilson
Journal:  Natl Vital Stat Rep       Date:  2011-11-03

6.  Accuracy of assisted reproductive technology information on the Massachusetts birth certificate, 1997-2000.

Authors:  Zi Zhang; Maurizio Macaluso; Bruce Cohen; Laura Schieve; Angela Nannini; Michael Chen; Victoria Wright
Journal:  Fertil Steril       Date:  2009-12-11       Impact factor: 7.329

7.  Gestational age estimates from singleton births conceived using assisted reproductive technology.

Authors:  William M Callaghan; Laura A Schieve; Patricia M Dietz
Journal:  Paediatr Perinat Epidemiol       Date:  2007-09       Impact factor: 3.980

8.  Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk.

Authors:  Carrie K Shapiro-Mendoza; Kay M Tomashek; Milton Kotelchuck; Wanda Barfield; Angela Nannini; Judith Weiss; Eugene Declercq
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

9.  Variation between last-menstrual-period and clinical estimates of gestational age in vital records.

Authors:  Cheng Qin; Jason Hsia; Cynthia J Berg
Journal:  Am J Epidemiol       Date:  2008-01-07       Impact factor: 4.897

10.  Assisted reproductive technology surveillance--United States, 2006.

Authors:  Saswati Sunderam; Jeani Chang; Lisa Flowers; Aniket Kulkarni; Glenda Sentelle; Gary Jeng; Maurizio Macaluso
Journal:  MMWR Surveill Summ       Date:  2009-06-12
View more
  10 in total

1.  Organophosphate flame-retardant metabolite concentrations and pregnancy loss among women conceiving with assisted reproductive technology.

Authors:  Carmen Messerlian; Paige L Williams; Lidia Mínguez-Alarcón; Courtney C Carignan; Jennifer B Ford; Craig M Butt; John D Meeker; Heather M Stapleton; Irene Souter; Russ Hauser
Journal:  Fertil Steril       Date:  2018-11       Impact factor: 7.329

2.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

3.  Birth Outcomes by Infertility Treatment: Analyses of the Population-Based Cohort: Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Marlene Anderka; Hafsatou Diop
Journal:  J Reprod Med       Date:  2016 Mar-Apr       Impact factor: 0.142

4.  Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-25       Impact factor: 8.661

5.  Adverse pregnancy outcomes after in vitro fertilization: effect of number of embryos transferred and plurality at conception.

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Mark D Hornstein; Daksha Gopal; Lan Hoang; Hafsatou Diop
Journal:  Fertil Steril       Date:  2015-05-05       Impact factor: 7.329

6.  Using Longitudinally Linked Data to Measure Severe Maternal Morbidity.

Authors:  Eugene R Declercq; Howard J Cabral; Xiaohui Cui; Chia-Ling Liu; Ndidiamaka Amutah-Onukagha; Elysia Larson; Audra Meadows; Hafsatou Diop
Journal:  Obstet Gynecol       Date:  2022-02-01       Impact factor: 7.661

7.  Birth Outcomes by Infertility Diagnosis Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Bruce Cohen; Hafsatou Diop
Journal:  J Reprod Med       Date:  2015 Nov-Dec       Impact factor: 0.142

8.  Urinary Concentrations of Phthalate Metabolites and Pregnancy Loss Among Women Conceiving with Medically Assisted Reproduction.

Authors:  Carmen Messerlian; Blair J Wylie; Lidia Mínguez-Alarcón; Paige L Williams; Jennifer B Ford; Irene C Souter; Antonia M Calafat; Russ Hauser
Journal:  Epidemiology       Date:  2016-11       Impact factor: 4.822

9.  Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Hafsatou Diop; Judy E Stern
Journal:  J Assist Reprod Genet       Date:  2016-06-18       Impact factor: 3.412

10.  Clinical implications of first-trimester ultrasound dating in singleton pregnancies obtained through in vitro fertilization.

Authors:  Agnese Maria Chiara Rapisarda; Edgardo Somigliana; Chiara Dallagiovanna; Marco Reschini; Maria Grazia Pezone; Veronica Accurti; Giuditta Ferrara; Nicola Persico; Simona Boito
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.